MCRB Seres Therapeutics, Inc.: מכפיל שווי פעילות להכנסות

serestherapeutics.com (MCRB) - לוגו תאגידי

Seres Therapeutics (MCRB) faces slow therapy adoption and a dependency on Nestlé Health. The temporary trajectory on the GURU.Markets EV/Sales chart demonstrates business adaptation, where 15000.00 determines this parameter level. Despite geopolitical barriers in biomaterial logistics, Seres Therapeutics (MCRB) maintains its leadership thanks to its proprietary platform for combating gastrointestinal infection relapses.

MCRB: יחס שווי פעילות להכנסות Seres Therapeutics 23.11.2025 - 20.11.2026

serestherapeutics.com - פילוחים אנליטיים ומדדי מפתח (MCRB)

- מחיר שוק ויעדי מחיר של אנליסטים:
- מדדי מזומנים ותזרימי מזומנים:
ניתוח ראשוני של החברה:Seres Therapeutics MCRB
מוצר מקורי של Seres Therapeutics

The ratio is calculated as the relationship between enterprise value and revenue, excluding the impact of debt obligations on capitalization. This metric measures the market valuation of every dollar of sales, allowing for the determination of the asset's overbought status. Amidst the management restructuring and asset reductions at Seres Therapeutics (MCRB), this coefficient becomes a critical efficiency indicator. Analyzing the EV/Sales multiple chart helps filter out market noise, as the line's dynamics reflect the real valuation momentum of the company.